NCT04715152View on ClinicalTrials.gov

ACB Versus IA Analgesia in Knee Arthroscopy

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 20, 2021

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
Postoperative Pain
Interventions
DRUG

ACB group

Patients will receive ultrasound-guided (USG) ACB with bupivacaine and dexamethasone 30 minutes before spinal anesthesia and sham intra-articular normal saline

DRUG

IA group

Patients will receive intra-articular bupivacaine and dexamethasone at the end of surgery and sham USG-ACB with normal saline

Trial Locations (1)

71515

Seham Mohamed Moeen, Asyut

All Listed Sponsors
lead

Assiut University

OTHER